FEB 25, 2019 6:44 PM PST

ADHD Drug Holds No Effect on Primate Prefrontal Cortex

WRITTEN BY: Nouran Amin

According to a new research study published eNeuro, investigations of methylphenidate (Ritalin) on neuronal activity in monkeys held no effects on the prefontal cortex unlike studies on mice and rats. The study opens the door to new questions behind why Ritalin improves attention in humans.

In the paper “The effects of methylphenidate (Ritalin) on the neurophysiology of the monkey caudal prefrontal cortex”, researchers refute their hypothesis that the caudal prefrontal cortex, a brain region critical for attention, is drugs main site of action in the brain.

Learn more about brain anatomy:

To conclude their studies, the researcher’s recorded large populations of neurons in the caudal prefrontal cortex region where two male macaque monkeys performed a demanding visual attention task. After administration of the drug, the researchers did not observe any significant differences in neuronal activity in comparison to the placebo, even at doses that improved the monkeys' performance on the task.

Such negative results do not push out any evidence that other regions of the prefrontal cortex could serve as possible sources of Ritalin's action in the brain. Additionally, the study highlights the challenges associated with translating preclinical research from rodents to nonhuman primates and the need for improved partnerships between scientists investigating common questions and using different animal models.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 05, 2022
Drug Discovery & Development
Insulin Nasal Spray Improves Cognitive Outcome for Diabetes Patients
MAY 05, 2022
Insulin Nasal Spray Improves Cognitive Outcome for Diabetes Patients
Diabetes is an increasingly common condition that affects at least 1 in 10 U.S adults. Millions more have prediabetes an ...
MAY 13, 2022
Drug Discovery & Development
Promising New Treatment for Cat Litter Parasite T. Gondii
MAY 13, 2022
Promising New Treatment for Cat Litter Parasite T. Gondii
Researchers have discovered a promising therapy for those suffering from toxoplasmosis, a disease caused by a parasite l ...
MAY 13, 2022
Drug Discovery & Development
Opioid Addiction Treatments Minimize Fetal Brain Changes
MAY 13, 2022
Opioid Addiction Treatments Minimize Fetal Brain Changes
The rise in opioid use, addiction, and overdose is a serious public health matter. Almost 850,000 people have died of dr ...
JUN 14, 2022
Coronavirus
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
JUN 14, 2022
Advances in Latest Coronavirus Research in the 2022 Ongoing Labroots Virtual Event Series
Labroots hosted its 3rd annual Coronavirus Conference Virtual Event Series on May 4, 2022. The speaker roster for this f ...
JUN 24, 2022
Cannabis Sciences
Decrease in Youth Substance Use During the Pandemic
JUN 24, 2022
Decrease in Youth Substance Use During the Pandemic
A review published in Child and Family Disaster Psychiatry found that youth substance use declined during the COVID-19 p ...
JUN 27, 2022
Drug Discovery & Development
Potential Gene Targets Identified for Treating Deafness
JUN 27, 2022
Potential Gene Targets Identified for Treating Deafness
Researchers have identified three mutations of the MINAR2 gene that are linked to deafness. They say that the mutations ...
Loading Comments...